About
Cancer immunotherapy imaging
Areas of Focus
Categories
Non-PharmaceuticalBiotech
Clinical Trials (20)
View allTotal Trials
20
As Lead Sponsor
10
As Collaborator
10
Total Enrollment
361
By Phase
EARLY_PHASE1: 3PHASE2: 9PHASE1: 7NA: 1
By Status
RECRUITING: 5COMPLETED: 5UNKNOWN: 4TERMINATED: 3WITHDRAWN: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline20 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07168785Collaborator
[18F]-AraG PET Imaging in LA HNSCC
EARLY_PHASE1Not yet recruiting
5 participants
Started: Oct 1, 2025 · Completed: Oct 31, 2027
NCT06107374Lead Sponsor
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
PHASE2Recruiting
20 participants
Started: Nov 1, 2023 · Completed: Mar 31, 2026
NCT06084806Lead Sponsor
Test-retest Evaluation of [18F]F-AraG PET
PHASE2Recruiting
10 participants
Started: Oct 31, 2023 · Completed: Oct 31, 2025
NCT04260256Lead Sponsor
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
PHASE2Recruiting
40 participants
Started: Mar 1, 2022 · Completed: Nov 30, 2026
NCT05096234Collaborator
18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma
PHASE1Terminated
2 participants
Started: Sep 28, 2021 · Completed: Oct 9, 2023
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...